Christopher Anzalone
Chief Executive Officer bei ARROWHEAD PHARMACEUTICALS, INC.
Vermögen: 106 Mio $ am 31.03.2024
Profil
Christopher Richard Anzalone ist ein Geschäftsmann, der die Benet Group LLC und Nanotope, Inc. gegründet hat und der 5 verschiedene Unternehmen geleitet hat. Derzeit ist er President, Chief Executive Officer & Director bei Arrowhead Pharmaceuticals, Inc. und Chairman & Chief Executive Officer von Calando Pharmaceuticals, Inc. (eine Tochtergesellschaft von Arrowhead Pharmaceuticals, Inc.). Dr. Anzalone ist außerdem im Vorstand von 5 weiteren Unternehmen. In seiner früheren Laufbahn war Dr. Anzalone Chief Executive Officer bei NanoInk, Inc., Partner bei Galway Partners LLC, Präsident, Chief Executive Officer & Director bei Nanotope, Inc. und Chief Executive Officer bei Benet Group LLC. Christopher Richard Anzalone promovierte an der University of California, Los Angeles, und erwarb einen Bachelor-Abschluss an der Lawrence University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
31.01.2024 | 3 715 048 ( 3,00% ) | 106 Mio $ | 31.03.2024 |
Aktive Positionen von Christopher Anzalone
Unternehmen | Position | Beginn |
---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Chief Executive Officer | 01.12.2007 |
Unidym, Inc.
Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Director/Board Member | 15.02.2010 |
Ablaris Therapeutics, Inc. | Director/Board Member | - |
Tego Biosciences Corp. | Director/Board Member | - |
Arrowhead Madison, Inc. | Director/Board Member | - |
Ehemalige bekannte Positionen von Christopher Anzalone
Unternehmen | Position | Ende |
---|---|---|
NanoInk, Inc.
NanoInk, Inc. Industrial MachineryProducer Manufacturing NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. | President | 01.01.2004 |
Galway Partners LLC | Corporate Officer/Principal | 01.01.2003 |
KRONOS BIO, INC. | Director/Board Member | - |
VIR BIOTECHNOLOGY, INC. | Director/Board Member | - |
░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Christopher Anzalone
University of California, Los Angeles | Doctorate Degree |
Lawrence University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
NanoInk, Inc.
NanoInk, Inc. Industrial MachineryProducer Manufacturing NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. | Producer Manufacturing |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
Nanotope, Inc.
Nanotope, Inc. Pharmaceuticals: MajorHealth Technology Nanotope, Inc. developed pharmaceutical products. The firm's products were used to regenerate specific tissues including neuronal, vascular, bone, myocardial, and cartilage. Its products targeted regeneration for prevention of paralysis associated with spinal cord injury and angiogenesis for advanced wound healing and the treatment of peripheral artery disease. The company was founded by Samuel I. Stupp and Christopher R. Anzalone and was headquartered in Skokie, IL. | Health Technology |
Roche Madison, Inc.
Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Roche Madison, Inc. provides gene transfer technologies to the pharmaceutical industry. The company was founded in 1995 by Jon Wolff, James Hagstrom and Vladimir Budker and is headquartered in Madison, WI. | Health Technology |
Unidym, Inc.
Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Electronic Technology |
Benet Group LLC
Benet Group LLC Financial ConglomeratesFinance Part of Arrowhead Pharmaceuticals, Inc., Benet Group LLC is a private equity firm. The private company is based in Washington. The American company was founded by Christopher Richard Anzalone. Benet Group was acquired by Arrowhead Pharmaceuticals, Inc. on March 13, 2008. | Finance |
Galway Partners LLC | Finance |
Ablaris Therapeutics, Inc. | |
Tego Biosciences Corp. | |
Arrowhead Madison, Inc. |